Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus

Archives of Ophthalmology

Volumn 123, Issue 9, 2005, Pages 1273-1275

  Colucciello, Michael ^a  

^a South Jersey Eye Physicians   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; ATORVASTATIN; HYDROCHLOROTHIAZIDE; INSULIN GLARGINE; QUINAPRIL; ROSIGLITAZONE; SERTRALINE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE REDUCTION; HUMAN; KIDNEY DISEASE; MALE; OUTCOMES RESEARCH; PERIPHERAL EDEMA; PRIORITY JOURNAL; RETINA MACULA EDEMA; VISUAL ACUITY; VISUAL IMPAIRMENT; CHEMICALLY INDUCED DISORDER; FLUORESCENCE ANGIOGRAPHY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; RETINA MACULA CYSTOID EDEMA; VISUAL DISORDER;

DIABETES MELLITUS, TYPE 2; FLUORESCEIN ANGIOGRAPHY; HUMANS; HYPOGLYCEMIC AGENTS; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; THIAZOLIDINEDIONES; VISION DISORDERS;

EID: 24944572295     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.9.1273     Document Type: Article

References (4)

1. Kermani A, Garg A. Thiazolidinedione-associated congestive heart failure and pulmonary edema. Mayo Clin Proc. 2003;78:1088-1091.
2. Niemeyer NV, Janney LM. Thiazolidinedione-induced edema. Pharmacotherapy. 2002;22:924-929.
3. Mudaliar S, Chang AR, Henry RR. Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications. Endocr Pract. 2003;9:406-416.
4. Harby K. Glitazone use may be associated with macular edema in diabetes. Available at: http://www.medscape.com/viewarticle/464732. Accessed July 7, 2004.